REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

HUMANCELL TECHNOLOGY Kft. (Hungary)

Main Activities: Outpatient Care Centers
Full name: HUMANCELL TECHNOLOGY Egeszsegugyi Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

HUMANCELL TECHNOLOGY Kft. is an enterprise based in Hungary. Its main office is in Budapest. It operates in the Outpatient Care Centers sector. The company was established on November 19, 2014. It currently has a total number of 1 (2024) employees. In 2023, the company reported a net sales revenue drop of 16.58%. Its total assets decreased by 47.64% over the same period. In 2023, HUMANCELL TECHNOLOGY Kft.’s net profit margin decreased by 8.75%.

Headquarters
Fiumei ut 7.
Budapest; Budapest; Postal Code: 1087

Contact Details: Purchase the HUMANCELL TECHNOLOGY Kft. report to view the information.

Basic Information
Total Employees:
Purchase the HUMANCELL TECHNOLOGY Kft. report to view the information.
Outstanding Shares:
Purchase the HUMANCELL TECHNOLOGY Kft. report to view the information.
Registered Capital:
Purchase the HUMANCELL TECHNOLOGY Kft. report to view the information.
Incorporation Date:
November 19, 2014
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after HUMANCELL TECHNOLOGY Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-16.58%▼
Total operating revenue
-10.36%▼
Operating profit (EBIT)
-557.69%▼
EBITDA
-77.42%▼
Net Profit (Loss) for the Period
-87.98%▼
Total assets
-47.64%▼
Total equity
-48.55%▼
Operating Profit Margin (ROS)
-11.98%▼
Net Profit Margin
-8.75%▼
Return on Equity (ROE)
6.85%▲
Quick Ratio
-0.18%▼
Cash Ratio
-0.05%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo